Analysis of the related factors in hepatitis C virus infection among hemophilic Patients in Isfahan, Iran

Hepatitis Monthly

Volumn 7, Issue 2, 2007, Pages 59-62

  Naini, Maziar Mojtabavi ^a   Derakhshan, Fatemeh ^a   Hourfar, Hamid ^a   Derakhshan, Roya ^a   Rajab, Fariborz Makarian ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hemophilia; Hepatitis b virus; Hepatitis C virus; Iran; Transfusion

Indexed keywords

BLOOD CLOTTING FACTOR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C VIRUS ANTIBODY; PEPTIDES AND PROTEINS; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD BANK; BLOOD CLOTTING DISORDER; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; CRYOPRECIPITATE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOPHILIA; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POSTTRANSFUSION HEPATITIS; PREVALENCE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE DYSFUNCTION; YOUNG ADULT;

EID: 84861138370     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Carmo RA, Oliveira GC, Guimaraes MD, Oliveira MS, Lima AA, Buzek SC, et al. Hepatitis C virus infection among Brazilian hemophiliacs: a virological, clinical and epidemiological study. Braz J Med Biol Res 2002; 35: 589-98.
2. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
3. Wharfe G, Smikle M, Dowe G, Buchner L, Choo-Kang E, Graham S, et al. Seroprevalence of hepatitis C virus in haemophiliacs in Jamaica. Hum Antibodies 2002; 11: 61-4.
4. Kasper DL FA, Braunwald E, Longo DL, Hauser SL, Jameson JL. Harrison’s Principles of Internal Medicine. New York: MC-Graw Hill 2005.
5. Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Rizza CR, Dusheiko GM, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors’ Organisation. Lancet 1997; 350: 1425-31.
6. Mansour-Ghanaei F, Fallah MS, Shafaghi A, Yousefi-Mashhoor M, Ramezani N, Farzaneh F, et al. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Med Sci Monit 2002; 8: CR797-CR800.
7. Lee C, Dusheiko G. The natural history and antiviral treatment of hepatitis C in haemophilia. Haemophilia 2002; 8: 322-9.
8. Maor Y, Bashari D, Kenet G, Lalezari S, Lubetsky A, Luboshitz J, et al. Hepatitis C at the Israeli national hemophilia center. Haemophilia 2006; 12: 68-74.
9. Silva LK, Silva MB, Lopes GB, Rodart IF, Costa FQ, Santana NP, et al. Prevalence of hepatitis C virus infection and HCV genotypes among hemophiliacs in the State of Bahia, Northeastern Brazil: analysis of serological and virological parameters. Rev Soc Bras Med Trop 2005; 38: 496-502.
10. Barbosa AP, Martins RM, Teles SA, Silva SA, Oliveira JM, Yoshida CF. Prevalence of hepatitis C Virus infection among hemophiliacs in Central Brazil. Mem Inst Oswaldo Cruz 2002; 97: 643-4.
11. Editorial. Zendegi (Iran Hemophilia Society Quarterly) 1997; 3: 2-3.
12. Karimi M, Yarmohammadi H, Ardeshiri R, Yarmohammadi H. Inherited coagulation disorders in southern Iran. Haemophilia 2002; 8: 740-4.
13. Alavian SM, Hajarizadeh B. Prevalence of HCV, HBV and HIV infection among hemophiliac patients. Hakim Research Journal 2003; 6: 45-51.
14. Kessler CM, Gellert GA, Mariani G, Patrick CF, Levine PH. Catalyzing global access to hemophilia care. Thromb Haemost 1995; 73: 896-7.
15. Lee CA. Towards achieving global haemophilia care--World Federation of Hemophilia programs. Haemophilia 1998; 4: 463-73.
16. Lee CA. World Federation of Hemophilia developing world programs. Haemophilia 1998; 4 Suppl 2: 59-63.
17. Lusher J, Kessler CM, Bajardi SE, Dickinson J, Augustyniak L. The National Hemophilia Foundation provides a model of a national blood monitoring system. Transfusion 1996; 36: 86-7.
18. Council TNHFMaSA. Standards and Criteria for the Care of Persons with Congenital Bleeding Disorders. New York: National Hemophilia Foundation 1994.
19. Fukuda Y, Nakano I, Katano Y, Toyoda H, Imoto M, Takamatsu J, et al. Assessment and treatment of liver disease in Japanese haemophilia patients. Haemophilia 1998; 4: 595-600.
20. Evatt BL. Observations from Global Survey 2001: an emerging database for progress. Haemophilia 2002; 8: 153-6.
21. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 1990; 76: 254-6.